A B S T R A C T Precise, direct measurement of bone calcium release (vo) has been accomplished using a continuous tracer administration (CTA) technique. Dietary calcium (96.97% 4OCa) is replaced by 4OCa (99.991% 40Ca) and blood levels of the naturally occuring isotope 48Ca are monitored by neutron activation analysis as a function of time. 48Ca abundance falls as this isotope is excreted and only partially replaced by release from bone. After a suitable period, an asymptotic abundance of 48Ca in serum, E, is approached which is the fraction of the turnover rate of the rapidly exchangeable calcium pools coming from the skeleton (E = V/Vt). E is determined with a standard error of 2%, providing a precise, sensitive index of v,. 13 studies in three normal men and one postmenopausal woman receiving maintenance estrogen show large intersubject variations in parameters of calcium metabolism using both CTA and pulse tracer administration (PTA) plus balance techniques. Induced hypercalcemia results in a prolonged decrease in vo. Glucocorticoid therapy initially and consistently induces a marked hypercalciuria while effects on most other parameters of calcium kinetics are variable. In two men E fell when testosterone was added to glucocorticoid treatment, consistent with the known antiosteolytic effect of androgens, despite the short period of study.
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Skeletal dynamics have been studied for many years using numerous techniques with variable degrees of success. In the investigation of skeletal kinetics many difficulties result from slow bone turnover (physiological destruction and replacement) and problems with representative measurements of skeletal composition in vivo. Techniques involving bone biopsy (1) (2) (3) have the disadvantages of representing only the portion of the skeleton sampled and of causing discomfort. Furthermore, translating static morphological observations (2, 3) into kinetic function may also lead to variation and error. Finally, quantitative in vivo roentgenography of the skeleton has not been sufficiently precise or reproducible to be useful in skeletal kinetic studies although recent advances have led to precise measurements at specific, local sites in the skeleton (4) .
Since a large part of bone is mineral and more than 99% of total body calcium is in the skeleton, calcium metabolism is inseparably connected to skeletal dynamics. Consequently, studies of calcium in man have been useful in understanding and quantitating skeletal metabolism. (6) . The basic principle is to measure in Cae a stable, naturally occurring calcium tracer which is liberated from the skeleton by bone resorption after elimination (or marked reduction) of it in the diet. At equilibrium the fraction of rapidly exchangeable calcium of skeletal origin is therefore the fraction of the natural abundance of this tracer in Cae, which is equivalent to vo/vt. Thus, a new parameter, E = Vo/Vt or osteolysis normalized by turnover of Cae, is defined and can be determined very precisely (orE < 2%) by direct measurement. In combination with other data, E can then be used to calculate a relatively precise estimate of v,.
To validate this CTA technique for measuring osteolysis, we carried out pilot studies in rats (7) and man (8) leading to the 13 studies in four adults re-'Abbreviations used in this paper: AA, asymptotic abundance; CTA, chronic tracer administration; PTA, pulse tracer administration; TRP, tubular reabsorption of phosphate. ported in this paper. In each case balance and PTA studies of calcium were also conducted. The validataion studies included normal adults in a basal state, in a hyperglucocorticoid state, and finally with appropriate androgen or estrogen added. One normal man was also studied after the stress of acute hypercalcemia.
METHODS Theory. The model used is similar to that suggested by Harris and Heaney (9) (see Fig. 1 ) to describe in vivo calcium kinetics. By continuously marking dietary or skeletal calcium with a tracer, its abundance in the rapidly exchangeable pools (Cae) asymptotically approaches an abundance level at equilibrium (E) directly proportional to the fraction of Vt flowing from the labeled origin; this assumes that, during the experimental period, calcium metabolism is in a steady state and tracer abundance does not change significantly in either the diet or the "stable" skeleton. Since our goal is to measure bone calcium resorption as directly and precisely as possible, we used the naturally occurring 48Ca as a uniformly distributed bone calcium tracer of known abundance and markedly reduced the level of this isotope in the diet. Serum 48Ca abundance declined to an equilibrium level, E, as excreted tracer was only partially replaced with tracer from bone. Correction of E for the small contribution of tracer from the diet results in Ec, which has the following relationship to v,,:
V,_Ivt = Ec or vo. = Ecvt, (2) where E0 is expressed as the fraction of 48Ca abundance in bone assumed in this work to be the same as the natural abundance of 48Ca. (10) (see Appendix A for the precise derivations of Eq. 2.)
In studies of calcium kinetics, the steady-state assumption is generally accepted under controlled conditions of constant intake. The new assumption necessary in the present work is that tracer abundance in the skeleton does not change significantly. Although calcium with reduced tracer content is deposited in bone during the experimental period, skeletal 4"Ca abundance is altered less than 0.025% per day in our studies. Furthermore, in view of evidence for random bone calcium resorption via osteocytic osteolysis (11) and the improbability that exchange processes and osteoclastic osteolysis occur specifically at sites of label concentration or deficiency, it is likely that tracer resorption would approximate that from a homogeneous pool in spite of gross morphological inhomogeneity (12) . This concept of random resorption of label from bone is also supported by the observation that Chromium sesquioxide, 500±5 mg, was given three times a day with meals as a continuous fecal marker (8, 14) during each phase of the study.
In three of the four subjects studied the following protocol was used (see Prednisone, 22.5 mg/day, was given during phases II and III.
Calcium kinetics were studied for 10 days during phase II starting with the injection of 10 11Ci 4"Ca 1 day after beginning the prednisone. Phase III commenced with injection of 7 yCi 47Ca and lasted for 10 days. During the first 5 days of this phase, the men received 100 mg testosterone propionate in oil intramuscularly each day and the female increased her maintenance Premarin dose to 10 mg each day.
In the fourth subject, B. D., a study of the effects of acute hypercalcemia was conducted between phases I and II. Phase I a commenced with a 2.0 g, 10 h intravenous infusion of enriched 40CaC12. Serum calcium reached 14.9 mg/100 ml at the end of the infusion and rapidly fell to 11.3 mg/100 ml where it remained for 2 days. By this time, cumulative urine output in excess of previous levels totalled 2 g and serum calcium levels became normal. 2 days after beginning the infusion, 7 uCi 4"Ca was injected and the effects of parenteral calcium loading on calcium kinetics were studied over a 15 day period.
Three types of studies were carried out simultaneously during each phase. Measurement of intake and collection of urine and feces with the use of a continuous fecal marker allowed classical balance calculations. PTA of 47Ca enabled classical kinetic studies (15) . Finally, CTA studies were possible, using the 48Ca tracer with the results being compared to balance and PTA studies to validate this technique.
Laboratory procedures. Fecal specimens were homogenized with 10% concentrated HNOs and a sample digested in Kjeldahl flasks with HNO3 and then HC1O4 to determine total fecal Ca and Cr content. The acid supernatant of the fecal homogenate was treated the same as urine and serum for "7Ca sp act and 48Ca abundance determinations. Acidified urine was filtered through ashless paper and a sample taken for total calcium determination; the balance was processed the same as serum for calcium tracer measurements. Calcih was precipitated from serum, urine, and the acid supernata of fecal homogenates by the addition of saturated (NH4)2C2 solution. The rinsed CaC204 precipitate was redissolved concentrated HNO3 and samples taken for tracers, 47 and 48Ca. On representative days, food portions identii with those consumed were homogenized and samples digest in HNO3 and HCI04 for dietary calcium determination. C cium concentrations of solutions were measured, using modification of the emission spectrophotometric technic of Loken, Teal, and Eisenberg (16) with a SD of 0.8%. 47 activity was determined to within 2% (SD) using a Nal ( scintillation counting system with an absolute efficiency 18% and background of 27.5 cpm utilizing the energy rar 0.70-1.44 MeV. 48Ca abundance was determined by neut activation analysis with a SD ranging from 2% to 4% (I Chromium levels were also determined by flame emiss spectrophotometry (8) .
Cakulations (8) . For PTA studies the first 10 days data were fitted with the equation X = Cie-x' + Cie-X-2, and used to calculate the parameters of calcium metaboli (18) . X is the measured tracer sp act or abundance in po( as a function of time. For comparison, calculations were a made by fitting with a three component equation:
Because of the uncertainties in interpretation of the th component, (see Discussion section) the flow parameters calcium kinetics (v) were calculated using only Eq. 3 and Eq. 4. Using the model in Fig. 1 , a two component exponen equation with an additional constant term was used to CTA data: X = Dle-xt + D2e-X2t + E, where Xi and X2 are the same as those in PTA studies. Beca of scatter in the data, large errors in D1, D2, X1, X2, anm result when all are estimated from the fit.
Therefore, by using XI and X2 from PTA data analysis more precise value for E can be obtained. However, if "ec librium" is reached within the desired precision, then first two terms of Eq. 5 become insignificant and X approac E as a nearly model-independent estimate of this param( of calcium kinetics. In using Eq. 5, dietary contributi of tracer to X were corrected for as described in Appendix Thus E, is obtained for use in Eq. 2.
Computations were made on an IBM 360/50 compu using variance weighted least-squares procedures to fit data to the equations and obtain error estimates of parameters. Standard statistical formula were used to quan the precision of balance data. Errors (ap) of the deri parameters of physiological interest (P = v, M, E, or were estimated from errors (0-,) ih (6) where P = f(P1,P2, p,-P.) (see footnote 3). Precision in this IEq. 6 gives ap2 values which agree within 1% of those obtained using the following expression: Classical kinetic studies using PTA have been conducted, using a number of different models for the rapidly miscible compartments, Ca,, (see Table IV ).
In early studies (19) (20) (21) Cae was often simplified to a single compartment, but it became apparent that at least two compartments were required to fit the first 10 days of data and compensate for excessive excretion of tracer during the intitial mixing phases (14) . Three compartments have also been used (20, 22, (24) used PTA data for 20 days and included a slower fourth compartment in their analyses, as also considered by others (5, 20) . In studies designed to look specifically Much work is needed to define which of these are important to skeletal metabolism and would best serve clinical and investigational needs.
In the present studies, sufficient data were not collected to define the very rapid component which is not necessary to determine the parameters of physiological interest. The commonly accepted two-component model for Ca. was used to fit the first 10 days of data for each study phase, so as to be comparable to the majority of calcium kinetic work to date. The physiologic role of the fourth component is unclear and may be reflecting processes in slowly equilibrating bone more than in Ca., as pointed out by Harris and Heaney (9) , who also suggested that a two-component analysis currently appears most appropriate. Nevertheless, for purposes of comparison, 20 days of base line for each subject in the present work was also fit with a three-component exponential function [corresponding to components 2, 3, and 4 of Neer et al. (24) ]. By doing this a much smoother fit was obtained for all of the data (see Fig. 3 ), even in the first portions of the curve, suggesting it may be necessary to consider at least 20 days of data and more than two components to represent Cae adequately.
Neer et al. (24) have pointed out that the physiologically important parameters of calcium metabolism, i.e., va, vf, vu, vow, and v,+ are independent of the configuration of pools used to describe Cae. All of these parameters of calcium metabolism can be determined by combining any two of the three techniques discussed in this paper, balance, PTA, and/or CTA. Table V compares estimated errors using different combinations of techniques. Errors of those parameters which appear to be significantly smaller by the use of one technique than by another are italicized. From these data, CTA and balance techniques apparently provide necessary and sufficient information to define the parameters of most physiologic interest with optimal precision. Furthermore, use of these two techniques can avoid the formulation of a model for Cae and the complex analysis required by PTA methods.
One of the advantages of determining EC from CTA studies is its relative independence of model configuration for Cae. That is not to say that the nature of Cae is not important in understanding skeletal kinetics. Nevertheless, using careful calcium balance and CTA techniques, EC and the other parameters of calcium metabolism including vo can be obtained directly and precisely without resorting to sophisticated model construction and complex, nonlinear least-squares analysis of the data. The following relationship can be used to obtain vt for these calculations without PTA data (see Appendix A for derivation):
Although in our CTA studies complex computer analysis was required to analyze the data, since tracer abundance was still about 3%c from its asymptotic value even after 20 days, it is theoretically possible to arrive at an estimate of E, much more simply.
Tracer may be added to the diet, at first in large quantities to get close to the asymptote and then at the constant level chosen with which to approach equilibrium. The average of the asymptotic abundance (AA) determinations in blood or urine (corrected for tracer from bone) made after a much shorter period of time than in our studies, could then be used to calculate E,: E, 1 -AA, where AA is expressed as a fraction of the dietary tracer abundance. Thus, combining this simplified technique with careful balance studies would yield optimal estimates of Va, Vf, Vu, vim, vo+, and vt.
Physiological observations. The " model independent" parameters of calcium flow from phase I of this study are generally within the normal range reported by others (see Table II ). The only exception is vf which is lower in the present studies. The large intersubject variation of calcium kinetic parameters observed by others (23, 24) is confirmed in this study, especially with regard to v,4, vo, and v.. Such wide variation makes normality of isolated calcium kinetic parameters difficult to establish. Serial studies in the same subject would undoubtedly be more sensitive and meaningful. Surprisingly, urinary calcium excretion in "normal" subjects apparently can be as much as 500 mg, cday, as shown both in these studies and those of Neer et al. (24) . Also significant negative calcium balances are often noted in "normal"subjects, in the present study as large as -260 mg/day and as large as -175 mg/day in the studies of Neer et al. (24) . Since balances of this nature would almost certainly lead to skeletal disease, which in fact does not occur frequently in such normal subjects, one might consider the possibility of calcium balance cycling around a net balance of zero. Present evidence is not sufficient to rule out this possibility or to distinguish it from the effects of changes in the subjects' routines, although attempts were made to avoid altering these as much as possible.
A definite diurnal cycle in v. was noted in the subjects in this study. The The acute effects (over a 15 day period) of intravenous calcium infusion on parameters of calcium kinetics are shown in Table I , B. D., phase I a. Definite decreases (P 0.05) are noted in vt, vZ, and EC, while other parameters remain unchanged, although there is a suggestion of a tendency for zt+ to be elevated. The drop in v. with serum calcium levels of 9.5-11.0 mg,' 100 ml suggests the parathvroid glands were not totally suppressed by continuing, significant hypercalcemia; otherwise, low parathyroid hormone levels would decrease tubular reabsorption of calcium and, or an elevated serum calcium would increase the filtered load of calcium, both of which would increase vu. Calcium loading results in prolonged suppression of zvg, possibly due to saturating sites of easily mobilizable calcium or "filling" sinks normally tending to lower serum calcium (e.g. uncalcified bone matrix). Thus, the "need" for parathyroid hormone to maintain normal blood calcium levels is decreased, leading to a decreased vow. Suppression of vow by hypercalcemia stimulation of calcitonin activity has not been ruled out but is less likely in view of its short action. This evidence supports the results and clinically significant hypothesis of Pak et al. (27) and Jowsey, Hoye, Pak, and Bartter (28) that transient hypercalcemia may produce prolonged reduction of excessive bone breakdown.
In examining the effects of glucocorticoid therapy on parameters of calcium metabolism (see Table III ), two facts become immediately apparent: (a) urinary calcium is uniformly increased, and (b) endogenous fecal excretion is uniformly decreased. However, changes in v. are much larger than in Vf, resulting in a large calcium loss from the body. Changes in other parameters of calcium metabolism are variable and apparently depend on the duration of corticoid administration. At least in the short term (the present study being conducted during the first 10 days of treatment) there is an elevation in Va noted in all four subjects; on the other hand, Wajchenberg, Pereira, Kieffer, and Ursic (23) noted a decrease in the fraction of dietary calcium absorbed after prolonged treatment (18 days) although their subjects varied their calcium intake between control and treatment periods and may have had an increased absolute value for Va. Also, there appears to be an increase in vt with treatment without any significant change in pool size (M1 + M2) being noted. No significant change in v,+ was apparent in the present studies, but Eisenberg (29) found it to be elevated after 6 wk of glucocorticoid therapy; however, Eisenberg and Gordan (21) Vw.. In any event, short-term glucocorticoid treatment did not increase the ratio of bone resorption to rapidly miscible pool turnover. Furthermore, except for the persistent calciuretic effect of glucocorticoids, the effects of these agents on other parameters of calcium metabolism are heavily dependent on the length of treatment.
It is fairly well established that androgens and estrogens decrease urinary calcium excretion and bone accretion (29, 30) while depressing vow to an even greater extent and result in increased Va and vA (9, 31) ; furthermore, morphological techniques have also been used to demonstrate a reduction in bone resorption by sex hormones (32) . However, the effects of such agents often take several weeks to manifest themselves as changes in skeletal calcium kinetics (9, 31) . Thus, it is not surprising that few significant effects were found during the first 10 days of treatment with tetosterone or high dose Premarin in these studies. It is interesting to note that in two subjects, S. P. and P. H., EC did decrease although the decrease had not yet manifested itself as a decrease in vo, suggesting that EC may be a very sensitive indicator of effects on osteolysis relative to total turnover rate and that the primary effect of these agents on calcium metabolism is to decrease osteolysis. Coincidentally, it is in these same two subjects that a tendency to increase va is also noted and in one of them, S. P., a significant decrease in Vf is observed. Perhaps one reason no effect of increased estrogen administration was seen in E. W. 
since vaI = Vt -Vi.
Tracer abundance in serum and urine (X=X8=Xu)
can be corrected for tracer coming from the diet. In the present experiments, since tracer is markedly reduced in the diet, a first approximation of the contribution of XI to X at any time is (1 -X)Xr, where
(1 -X) represents an approximation of the fraction of calcium in pool I of dietary origin accumulated from the beginning of the study, and Xi the abundance of tracer in the diet. Thus, X may be corrected for tracer from diet:
XC~X -(1 -X)Xi. 
Appendix B. As calculated from data in the present studies, the relative error in v,+ is slightly larger than in vo using PTA and balance data. The disparity results because the magnitude of the errors for each of the three component determinations of t,+ is about the same as for each of the four components of va, while the larger value for vo (due tz the negative balances in the present studies) makes the percent error smaller. The component determinations may be derived as follows:
This correction can be made precise by substituting Xc for X in the diet portion of the expression, i.e.
(1 -X)XI becomes (1-X)XI, and solving for Xc:
X -XI Using corrected data, Xc, the equilibrium abundance of tracer in Cae becomes Ec reflecting the nondietary influx of tracer. Substituting into Eq. 9, V0... = Ecvt, (12) since E = Ec, X, = 1.00, and XI = 0 using dietcorrected data.
The turnover rate of Cae can also be calculated from EC and balance data, The following relationship comes Vo+ = Vt -V -u;
Vow= VO+ -t"I = Vt -Vf -Vu -VI + VF + VU = Vt -Vf + VF + VI.
Thus, errors in the first two terms of each expression, vt and vf, are identical; the errors in the third terms of each expression, v. and VF, respectively, are similar using continuous fecal marking with chromium; and the error in VI is assumed to be negligible by experimental design.
Appendix C. The least-squares fits to the 47Ca data for each subject during base-line phase I are as follows with X in units of fraction of administered dose per gram of calcium in M1 at time t in units of days.
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